United Kingdom

Linical Co Ltd (2183.T)

2183.T on Tokyo Stock Exchange

20 Aug 2018
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Linical Co., Ltd. is a Japan-based company mainly engaged in the contract research organization (CRO) business for drug companies. The Company operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development... (more)


Beta: 1.18
Market Cap(Mil.): ¥37,208.96
Shares Outstanding(Mil.): 24.74
Dividend: 11.00
Yield (%): 0.66


  2183.T Industry Sector
P/E (TTM): 24.79 85.68 32.76
EPS (TTM): 60.67 -- --
ROI: 28.87 1.78 14.61
ROE: 40.27 3.28 16.33

BRIEF-Linical to take out loans of 4 bln yen

* Says it will take out loans of 4 billion yen in total, on April 12, due to unit LINICAL USA, INC will acquire stake in Accelovance, Inc

11 Apr 2018

BRIEF-Linical unit to buy Accelovance for 3.47 bln yen

* Says its wholly owned subsidiary LINICAL USA INC and LINICAL USA's wholly owned subsidiary Magnolia Acquisition Corp signed a contract, regarding merger between Magnolia Acquisition Corp and U.S.-based firm Accelovance,Inc

27 Mar 2018

Earnings vs. Estimates